心胸血管外科
意向地址: 浙江省
自我评价: 教学:自 2018 年取得教师资格证以来暂未担任教学工作。国家级:2021 年 04 月-2026 年.03 月 中国医药教育协会临床抗感染药物评价与管理分会 委员省级:2021 年 09 月-2024 年.08 月 黑龙江省慢性病协会血管外科分会 秘书长兼常务委员临床:◆个人工作量:月均手术量 40~60 台。科研:◆主持 院博士基金 1 项(2019 年度,10 万,在研中未结题)◆文章:1、Jiang W,Li G,Li W,Wang H,Li H,Tang B,Liu B,Jiang H,Sun X.Sodium orthovanadate overcomes Sorafenib resistance of hepatocellular carcinoma cells by inhibiting Na+/K+-ATPase activity and hypoxiz induciblepathways.Scientific Reports 2018;8:9706 DOI:10.1038/S41598-018-28010-y.2、ZhengWei a ,⁎,1,WenjingJiang b ,1,HengzhenWang a ,HaliLi a ,BoTang a ,BingLiu a ,HongchiJiang b , Xueying Sun b ;The IL-6/STAT3 pathway regulates adhesion molecules and cytoskeleton of endothelial cells in thromboangiitis obliterans cellular signaling;44(2018)118-1263、Yu Q 1 , Jiang W 1 , Li D 1 , Gu M 1 , Liu K 1 , Dong L 1 , Wang C 1 , Jiang H 1 , Dai W 1 ; Sodium orthovanadate inhibits growth and triggers apoptosis of human anaplastic thyroid carcinoma cells in vitro and in vivo Oncol Lett. 2019 May;17(5):4255-4262.4、Dan Li 1 , Wang C 1 , Ma P 1 , Yu Q 1 , Gu M 1 , Dong L 1 , Jiang W 1 , Pan S 2 , Xie C 1 , Han J 1 , Lan Y 1 , Sun J 1 ,Sheng P 1 ,Liu K 1 , Wu Y 1 , Liu L 1 , Ma Y 3 , Jiang H 4,5 ; PGC1α promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC expression to reverse the Warburg effect Cell Death Dis. 2018 May 1;9(5):466.5、Lin H 1 , Jiang X 1 , Zhu H 2 , Jiang W 1 , Dong X 1 , Qiao H 1 , Sun X 3,4 , Jiang H 5 . 2ME2 inhibits the activated hypoxia-inducible pathways by cabozantinib and enhances its efficacy against medullary thyroid carcinoma Tumour Biol. 2016 Jan;37(1):381-916、Lixin Ma 1 , Bo Zhai 2,3 , Huaqiang Zhu 4 , Weidong Li 2,3 , Wenjing Jiang 3 , Liwang Lei 1 , Shujun Zhang 5 , Haiquan Qiao 1, Xian Jiang 1,3 * and Xueying Sun; The miR-141/neuropilin-1 axis is associated with the clinicopathology and contributes to the growth and metastasis of pancreatic cancer ,Cancer Cell Int. 2019 Sep 27;19:2487、Wang Hengzhen; Jiang Wenjing; Wang Haijun; Wei Zheng; Li Hali; Yan Haichao; Han Peng Identification of Mutation Landscape and Immune Cell Component for Liver Hepatocellular Carcinoma Highlights Potential Therapeutic Targets and Prognostic Markers [J]. Frontiers in Genetics, 2021 DOI: 10.3389/FGENE.2021.737965